Pcn12 - Comparative Analysis of Profiles of Stage Iiib/Iv NSCLC Patients by Time From Diagnosis to First Treatment in Western Europe

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.095
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pcn14 - Comparative Analysis of Profiles of Stage Iiib/Iv NSCLC Patients by Time From Diagnosis to First Treatment in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

P2.01-91 Treatment Patterns in Patients With Stage IIIB-IV NSCLC in Clinical Practice: Retrospective Analysis of a UK Trust Database

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.01-48 Predictive Factors in NSCLC Patients With Stage IIIB/IV Treated With First Line Platinum-Doublet Chemotherapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

PCN12 Survival Patterns by Line of Treatment of Stage IV Colorectal (CRC) Patients From Local Oncology Practice in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

P23 Stage IIIb NSCLC and Curative Intention Treatment: Difficulties and Disparities in Brazil

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Effects of Microwave Ablation or Its Combination With Whole-Body Chemotherapy on Serum Vascular Endothelial Growth Factor Levels in Patients With Stage IIIB/IV NSCLC

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2015English

P3.13-10 Factors Associated With Long-Term Survival of Stage IV NSCLC Patients on First-Line EGFR-Targeting Therapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.17-27 IMpower030: Phase III Study Evaluating Neoadjuvant Treatment of Resectable Stage II-IIIB NSCLC With Atezolizumab + Chemotherapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Efficacy and Safety of First-Line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma

JAMA Oncology
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy